PHTS Telemedizin Provides Telemedicine Solutions

SHL Telemedicine LtdSHL Telemedicine Ltd. (SWX:SHLTN), a leading provider and developer of advanced personal telemedicine solutions, is pleased to announce that its wholly owned German subsidiary PHTS Telemedizin is part of an integrated care services contract in the state of Schleswig-Holstein whereby family doctors, physicians and hospitals in Schleswig-Holstein will refer patients of public health insurance companies IKK Nord and IKK-Direkt suffering from chronic heart illnesses to PHTS Telemedizin for the reception of telemedicine services.

PHTS Telemedizin (www.phts.de), through its monitoring centre based in Dusseldorf, will provide these patients suffering from chronic heart illnesses improved care around the clock.

Some of the PHTS Telemedizin (www.phts.de) partners in this integrated care solution are: IKK Nord, IKK-Direkt, Deutscher Hausärzteverband, Landesverband Schleswig-Holstein, Ärztegenossenschaft Schleswig-Holstein eG, 4K-Verbund der Kliniken Medizinisches Zentrum Klinikum Itzehoe, Westküstenkliniken Heide und Brunsbüttel gGmbH, FEK Friedrich-Ebert-Krankenhaus Neumünster GmbH, Universitätsklinikum Schleswig- Holstein Kiel and Universitätsklinikum Schleswig-Holstein Lubeck.

Eyal Lewin, Managing Director of PHTS Telemedizin (www.phts.de), comments: "Schleswig-Holstein's vast territory is well suited for the application of cardiac telemedicine solutions and I am confident in our ability to improve the quality of care for the chronically ill."

Erez Alroy, Co-CEO of SHL Telemedicine, adds: "We are very pleased with the development in the German market. The cooperation with the health community in Schleswig-Holstein emphasizes PHTS Telemedizin's leading position in the German telemedicine market and its continuing growth and progress. The goal of this contract is to improve the quality of care and quality of life for chronically ill heart patients and at the same time achieve better cost-efficiency."

About SHL TeleMedicine
SHL TeleMedicine Ltd. is a leading provider and developer of advanced personal telemedicine solutions to individuals and to the healthcare community. As a provider of remote health services in cardiology and in other medical areas, SHL maintains business operations in the US, Europe and Israel. SHL is listed on the SWX Swiss Exchange, symbol SHLTN. For more information see www.shl-telemedicine.com.

Most Popular Now

AI Distinguishes Glioblastoma from Look-…

A Harvard Medical School–led research team has developed an AI tool that can reliably tell apart two look-alike cancers found in the brain but with different origins, behaviors, and treatments. The...

Overcoming the AI Applicability Crisis a…

Opinion Article by Harry Lykostratis, Chief Executive, Open Medical. The government’s 10 Year Health Plan makes a lot of the potential of AI-software to support clinical decision making, improve productivity, and...

Smart Device Uses AI and Bioelectronics …

As a wound heals, it goes through several stages: clotting to stop bleeding, immune system response, scabbing, and scarring. A wearable device called "a-Heal," designed by engineers at the University...

Dartford and Gravesham Implements Clinis…

Dartford and Gravesham NHS Trust has taken a significant step towards a more digital future by rolling out electronic test ordering using Clinisys ICE. The trust deployed the order communications...

AI Body Composition Measurements can Pre…

Adiposity - or the accumulation of excess fat in the body - is a known driver of cardiometabolic diseases such as heart disease, stroke, type 2 diabetes, and kidney disease...